Non-clustered protocadherin

Area of Science:

• Molecular Biology
• Neuroscience
• Genetics

Background:

• The cadherin superfamily includes classical cadherins, desmosomal cadherins, and protocadherins (PCDHs).
• Genomic and phylogenetic analyses distinguish PCDHs from other cadherins and classify them into clustered and non-clustered groups.
• Non-clustered PCDHs are further categorized into δ1, δ2, and ε subgroups based on sequence analysis.

Purpose of the Study:

• To classify non-clustered protocadherins (PCDHs) using phylogenetic analysis.
• To investigate the expression patterns and functional roles of non-clustered PCDHs in the nervous system.
• To explore the involvement of non-clustered PCDHs in cell adhesion, signaling, and disease.

Main Methods:

• Phylogenetic analysis of full-length non-clustered PCDH sequences.
• Analysis of spatiotemporal expression patterns in the developing and mature brain.
• Investigation of cell-cell adhesion properties and protein interaction partners.
• Review of existing literature on PCDH involvement in neurological diseases and cancer.

Main Results:

• Non-clustered PCDHs were phylogenetically classified into δ1, δ2, and ε subgroups.
• These proteins are predominantly expressed in the nervous system with diverse spatiotemporal patterns, particularly in cortical and subcortical regions.
• Non-clustered PCDHs exhibit homophilic/heterophilic cell adhesion and diverse cell signaling partnerships.
• Isoforms with differential cytoplasmic sequences suggest distinct intracellular signaling capabilities.
• Involvement in neurological disorders (autism, schizophrenia, epilepsy, cognitive impairment) and potential tumor suppressor roles were noted.

Conclusions:

• Non-clustered PCDHs are key regulators of neural circuit formation and maintenance through cell adhesion and signaling.
• Their diverse isoforms and signaling partnerships underscore complex regulatory functions.
• Aberrant PCDH function is implicated in significant human diseases, warranting further investigation.